Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa.
Mita K, Izumi K, Goriki A, Tasaka R, Hatayama T, Shima T, Kato Y, Kamiyama M, Inoue S, Tanaka N, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Kadono Y, Mizokami A. Mita K, et al. Cancers (Basel). 2024 Jan 24;16(3):508. doi: 10.3390/cancers16030508. Cancers (Basel). 2024. PMID: 38339260 Free PMC article.
Impact of neutrophil-to-lymphocyte ratio on effects of targeted therapy for metastatic renal cell carcinoma patients with extrapulmonary metastasis.
Teishima J, Ohara S, Sadahide K, Fujii S, Kitano H, Kobatake K, Shinmei S, Hieda K, Inoue S, Hayashi T, Mita K, Matsubara A. Teishima J, et al. Among authors: mita k. Can Urol Assoc J. 2017 May;11(5):E207-E214. doi: 10.5489/cuaj.4106. Epub 2017 May 9. Can Urol Assoc J. 2017. PMID: 28503236 Free PMC article.
Usefulness of personalized three-dimensional printed model on the satisfaction of preoperative education for patients undergoing robot-assisted partial nephrectomy and their families.
Teishima J, Takayama Y, Iwaguro S, Hayashi T, Inoue S, Hieda K, Shinmei S, Kato R, Mita K, Matsubara A. Teishima J, et al. Among authors: mita k. Int Urol Nephrol. 2018 Jun;50(6):1061-1066. doi: 10.1007/s11255-018-1881-2. Epub 2018 May 9. Int Urol Nephrol. 2018. PMID: 29744824
Predictors of poor response to first-generation anti-androgens as criteria for alternate treatments for patients with non-metastatic castration-resistant prostate cancer.
Fukuoka K, Teishima J, Nagamatsu H, Inoue S, Hayashi T, Mita K, Shigeta M, Kobayashi K, Kajiwara M, Kadonishi Y, Tacho T, Matsubara A. Fukuoka K, et al. Among authors: mita k. Int Urol Nephrol. 2020 Jan;52(1):77-85. doi: 10.1007/s11255-019-02281-4. Epub 2019 Sep 24. Int Urol Nephrol. 2020. PMID: 31552574
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial.
Izumi K, Shima T, Mita K, Kato Y, Kamiyama M, Inoue S, Tanaka N, Hoshi S, Okamura T, Yoshio Y, Enokida H, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Kadono Y, Mizokami A. Izumi K, et al. Among authors: mita k. Eur Urol Open Sci. 2022 May 19;41:16-23. doi: 10.1016/j.euros.2022.04.016. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35813251 Free PMC article.
493 results